当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第18期
编号:669778
不同起始剂量的帕立骨化醇治疗血液透析伴继发性甲状旁腺亢进患者的有效性
http://www.100md.com 2021年11月30日 中国现代医生 2021年第18期
     鲁华 霍鹏飞 王晶 刘倩 薛明伟 刘爱翔

    [关键词] 血液透析;继发性甲状旁腺功能亢进;帕立骨化醇;有效性

    [中图分类号] R587.1? ? ? ? ? [文献标识码] B? ? ? ? ? [文章编号] 1673-9701(2021)18-0043-04

    Effectiveness of different starting doses of paricalcitol in the treatment of hemodialysis patients with secondary hyperparathyroidism

    LU Hua? ?HUO Pengfei? ?WANG Jing? ?LIU Qian? ?XUE Mingwei? ?LIU Aixiang

    Department of Nephrology, Xingtai People′s Hospital in Hebei Province, Xingtai? ?054000, China

    [Abstract] Objective To explore the efficacy of different starting doses of pericalcitol (PCT) in the treatment of hemodialysis patients with secondary hyperparathyroidism (SHPT) for 12 weeks. Methods The research subjects were 30 patients with maintenance hemodialysis combined with SHPT who were admitted to our hospital from June ......

您现在查看是摘要页,全文长 9761 字符